DAX24.340 +0,2%Est505.746 -0,1%MSCI World4.343 -0,1%Top 10 Crypto11,38 -1,7%Nas23.597 -0,1%Bitcoin73.781 -0,3%Euro1,1791 +0,1%Öl61,58 -1,1%Gold4.528 +1,1%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Novo Nordisk A3EU6F DroneShield A2DMAA Rheinmetall 703000 Allianz 840400 Lufthansa 823212 Amazon 906866 Tesla A1CX3T Bayer BAY001 Deutsche Telekom 555750 Alphabet A (ex Google) A14Y6F BYD A0M4W9 Siemens Energy ENER6Y D-Wave Quantum A3DSV9 Deutsche Bank 514000
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX schließt vor Weihnachten etwas höher -- Alphabet kauft Intersect -- Novo Nordisk, D-Wave, Lufthansa, Palantir, TUI, Microsoft, Bitcoin, Gold im Fokus
Top News
S&P 500-Wert Morgan Stanley-Aktie: So viel hätten Anleger mit einem Investment in Morgan Stanley von vor 5 Jahren verdient S&P 500-Wert Morgan Stanley-Aktie: So viel hätten Anleger mit einem Investment in Morgan Stanley von vor 5 Jahren verdient
NASDAQ Composite Index-Titel Starbucks-Aktie: So viel Verlust hätte eine Starbucks-Investition von vor 5 Jahren eingebracht NASDAQ Composite Index-Titel Starbucks-Aktie: So viel Verlust hätte eine Starbucks-Investition von vor 5 Jahren eingebracht
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

DBV TECHNOLOGIES Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
3,19 EUR -0,26 EUR -7,41 %
BMN
3,13 EUR -0,30 EUR -8,61 %
PAR
DBV TECHNOLOGIES jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.642,21 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA1JWB7

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINFR0010417345

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolDBVTF

DBV TECHNOLOGIES Aktien News

DatumMeistgelesen
GlobeNewswireDBV Technologies to Participate in Upcoming EAACI 2024 Congress
GlobeNewswireDBV Technologies Announces Plan to Implement ADS Ratio Change
GlobeNewswireDBV Technologies Announces Results of its 2024 Combined General Meeting
GlobeNewswireDBV Technologies to Participate in Upcoming Investor Conferences
GlobeNewswireDBV Technologies Reports First Quarter 2024 Financial Results and Business Update
GlobeNewswireCombined General Meeting of May 16, 2024
GlobeNewswireInformation regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024
GlobeNewswireDBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document
GlobeNewswireDBV Technologies Reports Full Year 2023 Financial Results and Business Update
GlobeNewswireDBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024
GlobeNewswireDBV Technologies to Participate in Upcoming AAAAI 2024 Congress
GlobeNewswireHalf-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
GlobeNewswireInformation regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023  
GlobeNewswireDBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers
GlobeNewswireMonthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023
GlobeNewswireDBV Technologies to Present New Data at ACAAI 2023
GlobeNewswireDBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results
GlobeNewswireDBV Technologies to Report Third Quarter 2023 Financial Results and Business Update
GlobeNewswireDBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer
GlobeNewswireMonthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023
GlobeNewswireDBV Technologies to Participate in Upcoming Investor Conference
GlobeNewswireDBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies and Reports Second Quarter and Half-Year 2023 Financial Results
GlobeNewswireDBV Technologies to Report First Half 2023 Financial Results and Provide a Corporate Update
GlobeNewswireMonthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2023
GlobeNewswireHalf-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
GlobeNewswireMonthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2023
GlobeNewswireDBV Technologies to Participate in Upcoming EAACI Congress 2023
GlobeNewswireDBV Technologies to Participate in Upcoming Investor Conference
GlobeNewswireDBV Technologies Announces New England Journal of Medicine Publication of Phase 3 EPITOPE Trial Data Evaluating Viaskin™ Peanut in Toddlers
GlobeNewswireDBV Technologies to Participate in Upcoming Investor Conference
GlobeNewswireDBV Technologies Reports First Quarter 2023 Financial Results
GlobeNewswireDBV Technologies Outlines Regulatory Path for Viaskin Peanut in Children 1 – 3 Years After Receiving Pre-BLA Responses from FDA
GlobeNewswireDBV Technologies Announces Results of its 2023 Ordinary and Extraordinary General Meeting
GlobeNewswireOrdinary and Extraordinary General Meeting of April 12, 2023
GlobeNewswireDBV Technologies Update
GlobeNewswireDBV Technologies Announces First Patient Screened in VITESSE Phase 3 Clinical Trial in Peanut-Allergic Children 4 – 7 Years Old
GlobeNewswireDBV Technologies announces filing of 2022 Annual Report on Form 10-K and 2022 Universal Registration Document
GlobeNewswireDBV Technologies Reports Full Year 2022 Financial Results and Business Update
GlobeNewswireDBV Technologies to Report Full Year 2022 Financial Results and Business Updates on March 2, 2023
GlobeNewswireDBV Technologies to Participate in Upcoming AAAAI 2023 Congress

DBV TECHNOLOGIES News

DBV TECHNOLOGIES News: auf dieser Seite finden Sie alle DBV TECHNOLOGIES News und Nachrichten zur DBV TECHNOLOGIES Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch DBV TECHNOLOGIES News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um DBV TECHNOLOGIES News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.